Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Optogenetics field of optogenetics has provided new insight into neuronal communication and complex brain function. Now, scientists eagerly anticipate clinical application of this technology, with the hope that it will help improve treatments for various neurological disorders. However, the translational hurdles are high. In this Perspective, we highlight the technical, practical, and regulatory hurdles that lie ahead along the path towards making optogenetic neuromodulation therapies a reality in the clinic.

Original publication

DOI

10.1126/scitranslmed.3003100

Type

Journal article

Journal

Science translational medicine

Publication Date

03/2013

Volume

5

Addresses

Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA. jwilliams@engr.wisc.edu

Keywords

Humans, Neurotransmitter Agents, Optogenetics, Translational Research, Biomedical